Literature DB >> 33128874

Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention.

Sarah E Rowan1, Rupa R Patel2, John A Schneider3, Dawn K Smith4.   

Abstract

Pre-exposure prophylaxis (PrEP) is highly effective in reducing HIV transmission but remains underutilised globally. Same-day PrEP prescribing and medication provision is an emerging implementation approach. The experiences of the three same-day PrEP programmes support the feasibility of the approach. Key elements of safe and effective same-day PrEP programmes include the ability to order laboratory tests at the time of the clinical visit and the ability to contact patients when laboratory results are available. Same-day PrEP has the potential to alleviate the attrition seen in usual care between initial evaluation and receipt of a PrEP prescription. A widespread application of same-day prescribing will be needed to assess its effect on PrEP usage.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33128874     DOI: 10.1016/S2352-3018(20)30256-3

Source DB:  PubMed          Journal:  Lancet HIV        ISSN: 2352-3018            Impact factor:   12.767


  7 in total

1.  Evaluation of an HIV Pre-Exposure Prophylaxis Referral System: From Sexual Health Center to Federally Qualified Health Center Pre-Exposure Prophylaxis Clinic.

Authors:  Rebecca Lillis; Jeremy Beckford; Joshua Fegley; Julia Siren; Bruce Hinton; Samuel Gomez; Stephanie N Taylor; Isolde Butler; Jason Halperin; Meredith Edwards Clement
Journal:  AIDS Patient Care STDS       Date:  2021-08-26       Impact factor: 5.944

2.  PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.

Authors:  Suzan M Walters; David Frank; Brent Van Ham; Jessica Jaiswal; Brandon Muncan; Valerie Earnshaw; John Schneider; Samuel R Friedman; Danielle C Ompad
Journal:  AIDS Behav       Date:  2021-10-09

3.  Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019.

Authors:  Heli Harvala; Claire Reynolds; Samreen Ijaz; Vicki Maddox; Sujan Dilly Penchala; Alieu Amara; Laura Else; Susan Brailsford; Saye Khoo
Journal:  Sex Transm Infect       Date:  2021-03-29       Impact factor: 3.519

4.  Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.

Authors:  Andrew Medina-Marino; Dana Bezuidenhout; Phuti Ngwepe; Charl Bezuidenhout; Shelley N Facente; Selly Mabandla; Sybil Hosek; Francesca Little; Connie L Celum; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

Review 5.  Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada.

Authors:  David C Knox; Robert Pilarski; Harvinder S Dhunna; Amit Kaushal; Jonathan D Adachi
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-08-30       Impact factor: 2.585

6.  Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.

Authors:  Kelika A Konda; Thiago S Torres; Gabriela Mariño; Alessandra Ramos; Ronaldo I Moreira; Iuri C Leite; Marcelo Cunha; Emilia M Jalil; Brenda Hoagland; Juan V Guanira; Marcos Benedetti; Cristina Pimenta; Heleen Vermandere; Sergio Bautista-Arredondo; Hamid Vega-Ramirez; Valdilea G Veloso; Carlos F Caceres; Beatriz Grinsztejn
Journal:  J Int AIDS Soc       Date:  2022-10       Impact factor: 6.707

7.  Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.

Authors:  Suzan M Walters; Joey Platt; Amarachi Anakaraonye; Sarit A Golub; Chinazo O Cunningham; Brianna L Norton; Jae M Sevelius; Oni J Blackstock
Journal:  AIDS Behav       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.